255 related articles for article (PubMed ID: 33291667)
1. AGE-RAGE Axis Stimulates Oxidized LDL Uptake into Macrophages through Cyclin-Dependent Kinase 5-CD36 Pathway via Oxidative Stress Generation.
Yashima H; Terasaki M; Sotokawauchi A; Matsui T; Mori Y; Saito T; Osaka N; Kushima H; Hiromura M; Ohara M; Fukui T; Yamagishi SI
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291667
[TBL] [Abstract][Full Text] [Related]
2. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis.
Terasaki M; Shibata K; Mori Y; Saito T; Matsui T; Ohara M; Fukui T; Hasumi K; Higashimoto Y; Nobe K; Yamagishi SI
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047475
[TBL] [Abstract][Full Text] [Related]
3. CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products.
Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
Ann N Y Acad Sci; 2001 Dec; 947():350-5. PubMed ID: 11795289
[TBL] [Abstract][Full Text] [Related]
4. A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression.
Terasaki M; Yashima H; Mori Y; Saito T; Matsui T; Hiromura M; Kushima H; Osaka N; Ohara M; Fukui T; Hirano T; Yamagishi SI
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646003
[TBL] [Abstract][Full Text] [Related]
5. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products.
Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
J Biol Chem; 2001 Feb; 276(5):3195-202. PubMed ID: 11035013
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.
Yao S; Miao C; Tian H; Sang H; Yang N; Jiao P; Han J; Zong C; Qin S
J Biol Chem; 2014 Feb; 289(7):4032-42. PubMed ID: 24366867
[TBL] [Abstract][Full Text] [Related]
7. WISP1 alleviates lipid deposition in macrophages via the PPARĪ³/CD36 pathway in the plaque formation of atherosclerosis.
Liu D; Wang X; Zhang M; Tian J; Liu M; Jin T; Pan J; Gao M; An F
J Cell Mol Med; 2020 Oct; 24(20):11729-11741. PubMed ID: 32851768
[TBL] [Abstract][Full Text] [Related]
8. Glucose-Dependent Insulinotropic Polypeptide Suppresses Foam Cell Formation of Macrophages through Inhibition of the Cyclin-Dependent Kinase 5-CD36 Pathway.
Terasaki M; Yashima H; Mori Y; Saito T; Shiraga Y; Kawakami R; Ohara M; Fukui T; Hirano T; Yamada Y; Seino Y; Yamagishi SI
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356896
[TBL] [Abstract][Full Text] [Related]
9. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells.
Nabi R; Alvi SS; Shah A; Chaturvedi CP; Iqbal D; Ahmad S; Khan MS
Life Sci; 2019 Oct; 235():116823. PubMed ID: 31476307
[TBL] [Abstract][Full Text] [Related]
10. Y-box binding protein 1 regulates ox-LDL mediated inflammatory responses and lipid uptake in macrophages.
Cao X; Zhu N; Li L; Zhang Y; Chen Y; Zhang J; Li J; Gao C
Free Radic Biol Med; 2019 Sep; 141():10-20. PubMed ID: 31153975
[TBL] [Abstract][Full Text] [Related]
11. CD36, serves as a receptor for advanced glycation endproducts (AGE).
Ohgami N; Nagai R; Ikemoto M; Arai H; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
J Diabetes Complications; 2002; 16(1):56-9. PubMed ID: 11872368
[TBL] [Abstract][Full Text] [Related]
12. Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum stress-C/EBP homologous protein pathway.
Tian H; Sun HW; Zhang JJ; Zhang XW; Zhao L; Guo SD; Li YY; Jiao P; Wang H; Qin SC; Yao ST
BMC Complement Altern Med; 2015 Jul; 15():230. PubMed ID: 26169264
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.
Ganesan R; Henkels KM; Wrenshall LE; Kanaho Y; Di Paolo G; Frohman MA; Gomez-Cambronero J
J Leukoc Biol; 2018 May; 103(5):867-883. PubMed ID: 29656494
[TBL] [Abstract][Full Text] [Related]
14. Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.
Sima AV; Botez GM; Stancu CS; Manea A; Raicu M; Simionescu M
J Cell Mol Med; 2010 Dec; 14(12):2790-802. PubMed ID: 19818091
[TBL] [Abstract][Full Text] [Related]
15. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway.
Yao S; Tian H; Miao C; Zhang DW; Zhao L; Li Y; Yang N; Jiao P; Sang H; Guo S; Wang Y; Qin S
J Lipid Res; 2015 Apr; 56(4):836-47. PubMed ID: 25635126
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase.
Fuhrman B; Volkova N; Aviram M
Atherosclerosis; 2002 Apr; 161(2):307-16. PubMed ID: 11888513
[TBL] [Abstract][Full Text] [Related]
17. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.
Marsche G; Weigle B; Sattler W; Malle E
FASEB J; 2007 Oct; 21(12):3075-82. PubMed ID: 17536039
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.
Yang X; Yao H; Chen Y; Sun L; Li Y; Ma X; Duan S; Li X; Xiang R; Han J; Duan Y
J Biol Chem; 2015 Sep; 290(36):21788-99. PubMed ID: 26187465
[TBL] [Abstract][Full Text] [Related]
19. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.
Chellan B; Reardon CA; Getz GS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1101-13. PubMed ID: 27079883
[TBL] [Abstract][Full Text] [Related]
20. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
